Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$31.71 - $43.0 $7.06 Million - $9.58 Million
-222,681 Closed
0 $0
Q1 2022

May 10, 2022

BUY
$29.88 - $37.04 $97,080 - $120,342
3,249 Added 1.48%
222,681 $8 Million
Q4 2021

Feb 01, 2022

BUY
$25.61 - $35.1 $135,502 - $185,714
5,291 Added 2.47%
219,432 $6.68 Million
Q3 2021

Nov 12, 2021

BUY
$33.54 - $40.55 $135,300 - $163,578
4,034 Added 1.92%
214,141 $7.21 Million
Q2 2021

Aug 12, 2021

BUY
$34.54 - $47.25 $255,596 - $349,650
7,400 Added 3.65%
210,107 $8.31 Million
Q1 2021

May 11, 2021

BUY
$42.51 - $63.78 $8.62 Million - $12.9 Million
202,707 New
202,707 $9.06 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.35B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Morningstar Investment Services LLC Portfolio

Follow Morningstar Investment Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morningstar Investment Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Morningstar Investment Services LLC with notifications on news.